Sectors
RCKT
Rocket Pharmaceuticals, Inc.
3.71
6 x 2.95
6 x 4.02
bid
ask
-
0.15
4.02%
03:10 PM
timesize
| Ytd | 5.56% | |
| 1y | 12.96% |
3.64
day range
3.80
2.53
52 week range
5.45
| Open | 3.77 | Prev Close | 3.86 | Low | 3.64 | High | 3.80 | Mkt Cap | 406.17M |
| Vol | 1.13M | Avg Vol | 2.20M | EPS | -0.17 | P/E | N/A | Forward P/E | -3.35 |
| Beta | 0.47 | Short Ratio | 7.72 | Inst. Own | 106.93% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 3.51 | 200-d Avg | 3.56 | 1yr Est | 40.93 |
| Income Statement | |||
| Operating Expenses | 46.92M | ||
| Research and Development Expense | 29.50M | ||
| Selling, General and Administrative Expense | 17.43M | ||
| Operating Income | -46.92M | ||
| Interest Expense | 473.00K | ||
| Income Tax Expense | 8.62M | ||
| Net Income | 123.21M | ||
| Net Income Common Stock | 123.21M | ||
| Net Income Common Stock (USD) | 123.21M | ||
| Consolidated Income | 123.21M | ||
| Earnings per Basic Share | 1.09 | ||
| Earnings per Basic Share (USD) | 1.09 | ||
| Earnings per Diluted Share | 1.08 | ||
| Earning Before Interest & Taxes (EBIT) | 132.31M | ||
| Earning Before Interest & Taxes (USD) | 132.31M | ||
| Weighted Average Shares | 112.84M | ||
| Weighted Average Shares Diluted | 114.51M | ||
| Balance Sheet | |||
| Cash and Equivalents | 226.33M | ||
| Cash and Equivalents (USD) | 226.33M | ||
| Investments | 59.24M | ||
| Investments Current | 59.24M | ||
| Current Assets | 289.55M | ||
| Property, Plant & Equipment Net | 67.42M | ||
| Total Assets | 423.10M | ||
| Debt Current | 2.98M | ||
| Total Debt | 24.80M | ||
| Current Liabilities | 31.32M | ||
| Debt Non-Current | 21.82M | ||
| Total Liabilities | 54.27M | ||
| Accumulated Retained Earnings (Deficit) | -1.37B | ||
| Accumulated Other Comprehensive Income | -106.00K | ||
| Shareholders Equity | 368.83M | ||
| Shareholders Equity (USD) | 368.83M | ||
| Assets Non-Current | 133.55M | ||
| Total Debt (USD) | 24.80M | ||
| Goodwill and Intangible Assets | 64.30M | ||
| Liabilities Non-Current | 22.95M | ||
| Trade and Non-Trade Payables | 28.34M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.10M | ||
| Net Cash Flow from Financing | 150.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 174.90M | ||
| Capital Expenditure | -8.00K | ||
| Net Cash Flow - Business Acquisitions and Disposals | 178.19M | ||
| Issuance (Purchase) of Equity Shares | 152.00K | ||
| Net Cash Flow from Investing | 214.36M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 36.18M | ||
| Net Cash Flow from Operations | -39.61M | ||
| Share Based Compensation | 7.42M | ||